- Pressemitteilung BoxID 528135
aap is granted European patent for LOQTEQ®, taking an important step toward global patent protection of the LOQTEQ® portfolio
"With this key patent for our innovative LOQTEQ® product family in the important European market we have reached another significant milestone", said Bruke Seyoum Alemu, CEO of aap Implantate AG. "One of aap's priorities is to build up a strong IP-based trauma portfolio around LOQTEQ®. The grant of the patent enables us to further strengthen and extend our competitive position in the trauma sector."
The LOQTEQ® product family holds numerous international patents that protect certain aspects of the stable-angle compression technology. The claims that the patent protects have led to a unique design combined with a high level of biomechanical stability. Advantages in respect of explantability were generated at the same time by reducing the risk that cold-welding poses.
"The European patent is for us a further proof of the success of our philosophy of developing innovative technologies in close cooperation with our customers", Bruke Seyoum Alemu said. "Our focus is always on ensuring that the resulting products offer our customers not only clinical but also economic advantages and thereby generate a sustainable benefit."
Diese Pressemitteilungen könnten Sie auch interessieren
Ab dem 27.04.18 sind 10 Titel der FilmConfect Home Entertainment GmbH in ausgesuchten Müller Märkten und Online erhältlich. Die Kooperation erfolgt...
Der Deutsche Druck- und Medientag, das zentrale Jahresevent der deutschen Druckbranche, findet in diesem Jahr am 28. und 29. Juni in Stuttgart...